These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 12494025

  • 21. Effect of lacidipine on blood pressure, vasoactive hormones, and haemorheology in elderly patients with essential hypertension.
    Shand BI, Gilchrist NL, Nicholls MG, Caesar M.
    J Hum Hypertens; 2000 Jul; 14(7):473-5. PubMed ID: 10918554
    [No Abstract] [Full Text] [Related]

  • 22. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.
    Makarounas-Kirchmann K, Glover-Koudounas S, Ferrari P.
    Clin Ther; 2009 Aug; 31(8):1652-63. PubMed ID: 19808126
    [Abstract] [Full Text] [Related]

  • 23. Calcium antagonists and atherosclerosis protection in hypertension.
    Hernández RH, Armas-Hernández MJ, Velasco M, Israili ZH, Armas-Padilla MC.
    Am J Ther; 2003 Aug; 10(6):409-14. PubMed ID: 14624278
    [Abstract] [Full Text] [Related]

  • 24. Lercanidipine in hypertension.
    Borghi C.
    Vasc Health Risk Manag; 2005 Aug; 1(3):173-82. PubMed ID: 17319103
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Ankle edema formation during treatment with the calcium channel blockers lacidipine and amlodipine: a single-centre study.
    Andrésdóttir MB, van Hamersvelt HW, van Helden MJ, van de Bosch WJ, Valk IM, Huysmans FT.
    J Cardiovasc Pharmacol; 2000 Aug; 35(3 Suppl 1):S25-30. PubMed ID: 11347858
    [Abstract] [Full Text] [Related]

  • 30. Potential modification of plaque behavior through the European lacidipine study on atherosclerosis.
    Bond MG, Mercuri M.
    J Cardiovasc Pharmacol; 1995 Aug; 25 Suppl 3():S11-6. PubMed ID: 8852539
    [Abstract] [Full Text] [Related]

  • 31. Radial artery compliance in essential hypertension: effects of antihypertensive therapy with lacidipine.
    Trazzi S, Santucciu C, Mancia G.
    J Hypertens Suppl; 1993 Dec; 11(6):S17-20. PubMed ID: 8169377
    [Abstract] [Full Text] [Related]

  • 32. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.
    Mancia G, Facchetti R, Parati G, Zanchetti A.
    Circulation; 2012 Jul 31; 126(5):569-78. PubMed ID: 22761453
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Preclinical study of the action of a calcium channel blocker during salt load].
    Godfraind T, Salomone S, Morel N, Ghisdal P.
    Bull Acad Natl Med; 1997 Feb 31; 181(2):289-98; discussion 299-300. PubMed ID: 9235228
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The calcium-channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE-deficient mouse.
    Cristofori P, Lanzoni A, Quartaroli M, Pastorino AM, Zancanaro C, Cominacini L, Gaviraghi G, Turton J.
    J Hypertens; 2000 Oct 31; 18(10):1429-36. PubMed ID: 11057430
    [Abstract] [Full Text] [Related]

  • 38. [Antihypertensive therapy. Can a calcium antagonist stop arteriosclerosis?].
    MMW Fortschr Med; 2001 May 31; 143(22):53. PubMed ID: 11460409
    [No Abstract] [Full Text] [Related]

  • 39. Emerging data on calcium-channel blockers: the COHORT study.
    Zanchetti A.
    Clin Cardiol; 2003 Feb 31; 26(2 Suppl 2):II17-20. PubMed ID: 12622322
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.